Enterprise of Rosatom State Corporation
Back to website

Industry news


NNSA Awards Funding to Accelerate Non-HEU-Based Production of Molybdenum-99 in the United States

The Department of Energy's (DOE) National Nuclear Security Administration (NNSA) announced the award of a cooperative agreement that accelerates the dual objectives of eliminating the use of proliferation-sensitive highly enriched uranium (HEU) in the production of medical isotopes and establishing reliable domestic supplies of Molybdenum-99 (Mo-99) to meet U.S. patient needs. Mo-99 is used frequently in common medical diagnostic procedures. The cooperative agreement with NorthStar Medical Radioisotopes, LLC provides support toward NorthStar's Mo-99 production capability using neutron-capture technology, which it is pursuing in partnership with the University of Missouri Research Reactor.

For more information visit nnsa.energy.gov


comments powered by Disqus